Lanean...
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
Chronic Myeloid Leukaemia is a myeloproliferative disorder driven by the t(9;22) chromosomal translocation coding for the chimeric protein BCR-ABL. CML treatment represents the paradigm of molecular therapy of cancer. Since the development of the tyrosine kinase inhibitor of the BCR-ABL kinase, the...
Gorde:
| Argitaratua izan da: | Blood Lymphat Cancer |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842740/ https://ncbi.nlm.nih.gov/pubmed/31807112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S228815 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|